TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
YARW

Yarrow Bioscience Inc

Healthcare · Biotechnology

25.50$ -2.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement YARW
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – +579.8% +132.2% -95.8% +4,638.8% -95.6% -48.8% -11.1% +18.2% +13.8%
– – – – – +297.7% – – – – –
– – +579.8% +132.2% -99.1% +20,976.3% -95.3% -48.8% -11.1% +18.2% +9.2%
– +285.3% +157.7% +82.7% +1.5% -19.0% -55.1% -5.9% -11.3% +89.8% -37.8%
– +122.3% +37.8% +135.8% +84.5% – – – -18.4% -1.4% -16.0%
– +225.7% +127.7% +90.7% +17.0% -405.5% – -12.7% -14.6% +48.7% -31.4%
– – – – – – -115.4% – – – –
– – – – – +376.7% +27.8% – – – –
– – – – – – – – – – –
– – – – – – – -97.1% – – +0.0%
– – – – – – – – – – –
– – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?